Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: N0BCCDD29882EN
Market Monitor Global

Abstracts

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

This report contains market size and forecasts of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Global, including the following market information:

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Aspirin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) include Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, by Type, 2021 (%)

• Aspirin
• Ibuprofen
• Naproxen
• Celecoxib
• Others

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, by Application, 2021 (%)

• Drug Store
• Hospital Pharmacies
• Online

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche (Genentech)
• Amgen
• B-MS
• Merck
• Pfizer
• Novartis
• Eli Lilly and Company
• Johnson & Johnson
• GSK
• Sanofi
• Boehringer Ingelheim
• Zhejiang Jiuzhou Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) OVERALL MARKET SIZE

2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size: 2021 VS 2028
2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market
3.2 Top Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies Ranked by Revenue
3.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Companies
3.4 Top 3 and Top 5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market
  3.6.1 List of Global Tier 1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Markets, 2021 & 2028
  4.1.2 Aspirin
  4.1.3 Ibuprofen
  4.1.4 Naproxen
  4.1.5 Celecoxib
  4.1.6 Others
4.2 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
  4.2.1 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2022
  4.2.2 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2023-2028
  4.2.3 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2021 & 2028
  5.1.2 Drug Store
  5.1.3 Hospital Pharmacies
  5.1.4 Online
5.2 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
  5.2.1 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2022
  5.2.2 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2023-2028
  5.2.3 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2021 & 2028
6.2 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
  6.2.1 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2022
  6.2.2 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2023-2028
  6.2.3 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2028
  6.3.2 US Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.3.3 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.3.4 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2028
  6.4.2 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.4.3 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.4.4 U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.4.5 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.4.6 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.4.7 Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.4.8 Benelux Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2028
  6.5.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.5.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.5.4 South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.5.5 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.5.6 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2028
  6.6.2 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.6.3 Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2028
  6.7.2 Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.7.3 Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.7.4 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028
  6.7.5 UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche (Genentech)
  7.1.1 Roche (Genentech) Corporate Summary
  7.1.2 Roche (Genentech) Business Overview
  7.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.1.4 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.1.5 Roche (Genentech) Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.2.4 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 B-MS
  7.3.1 B-MS Corporate Summary
  7.3.2 B-MS Business Overview
  7.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.3.4 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.3.5 B-MS Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.4.4 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.5.4 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.6.4 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Eli Lilly and Company
  7.7.1 Eli Lilly and Company Corporate Summary
  7.7.2 Eli Lilly and Company Business Overview
  7.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.7.4 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly and Company Key News
7.8 Johnson & Johnson
  7.8.1 Johnson & Johnson Corporate Summary
  7.8.2 Johnson & Johnson Business Overview
  7.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.8.4 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.8.5 Johnson & Johnson Key News
7.9 GSK
  7.9.1 GSK Corporate Summary
  7.9.2 GSK Business Overview
  7.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.9.4 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.9.5 GSK Key News
7.10 Sanofi
  7.10.1 Sanofi Corporate Summary
  7.10.2 Sanofi Business Overview
  7.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.10.4 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.10.5 Sanofi Key News
7.11 Boehringer Ingelheim
  7.11.1 Boehringer Ingelheim Corporate Summary
  7.11.2 Boehringer Ingelheim Business Overview
  7.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.11.4 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.11.5 Boehringer Ingelheim Key News
7.12 Zhejiang Jiuzhou Pharmaceutical
  7.12.1 Zhejiang Jiuzhou Pharmaceutical Corporate Summary
  7.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
  7.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
  7.12.4 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2017-2022)
  7.12.5 Zhejiang Jiuzhou Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Opportunities & Trends in Global Market
Table 2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers in Global Market
Table 3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints in Global Market
Table 4. Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Global Market
Table 5. Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
Table 9. List of Global Tier 1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2023-2028
Table 30. Roche (Genentech) Corporate Summary
Table 31. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 32. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 35. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 36. B-MS Corporate Summary
Table 37. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 38. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 41. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 44. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 47. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 50. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 51. Johnson & Johnson Corporate Summary
Table 52. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 53. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 54. GSK Corporate Summary
Table 55. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 56. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 59. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 60. Boehringer Ingelheim Corporate Summary
Table 61. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 62. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)
Table 63. Zhejiang Jiuzhou Pharmaceutical Corporate Summary
Table 64. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 65. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type in 2021
Figure 2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application in 2021
Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2021
Figure 8. By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 12. US Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 16. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 24. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 30. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2017-2028
Figure 33. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2017-2028
Figure 37. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)